0001564590-22-039861.txt : 20221229 0001564590-22-039861.hdr.sgml : 20221229 20221229090047 ACCESSION NUMBER: 0001564590-22-039861 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221229 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221229 DATE AS OF CHANGE: 20221229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 221496432 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 356 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 356 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 8-K 1 acer-8k_20221229.htm 8-K acer-8k_20221229.htm
false 0001069308 0001069308 2022-12-29 2022-12-29

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): December 29, 2022

 

ACER THERAPEUTICS INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-33004

 

32-0426967

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

One Gateway Center, Suite 356
300 Washington Street

Newton, Massachusetts

 

02458

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (844) 902-6100

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

  Name of Each Exchange on Which Registered

Common Stock, $0.0001 par value per share

ACER

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01.Other Events.

On December 29, 2022, Acer Therapeutics Inc. issued a press release entitled “Acer Therapeutics Compliant with All Nasdaq Listing Criteria,” a copy of which is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01.Financial Statements and Exhibits.

(d)  Exhibits

 

Exhibit

No.

 

Description

 

 

 

 

 

99.1

 

Press release issued by Acer Therapeutics Inc. dated December 29, 2022, entitled “Acer Therapeutics Compliant with All Nasdaq Listing Criteria.”

 

 

 

104

 

Cover page interactive data file (embedded within the inline XBRL document).

 

 

 

 

 


2

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: December 29, 2022

ACER THERAPEUTICS INC.

 

 

 

 

 

 

By:

/s/ Harry S. Palmin 

 

 

 

Harry S. Palmin

 

 

 

Chief Financial Officer

 

 

 

3

 

 EX-99.1 2 acer-ex991_22.htm EX-99.1 acer-ex991_22.htm

Exhibit 99.1

Acer Therapeutics Compliant with All Nasdaq Listing Criteria

 

NEWTON, MA – Dec. 29, 2022 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that The Nasdaq Stock Market LLC has formally notified Acer that the company has regained compliance with the $35 million market value of listed securities requirement, and otherwise satisfies all other criteria necessary, for continued listing on The Nasdaq Capital Market. Accordingly, the listing matter is now closed and the previously-scheduled hearing before the Nasdaq Hearings Panel has been cancelled.

 

About Acer Therapeutics

Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. In the U.S., OLPRUVA™ (sodium phenylbutyrate) is approved for the treatment of urea cycle disorders (UCDs) involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). Acer is also advancing a pipeline of investigational product candidates for rare and life-threatening diseases, including: OLPRUVA™ (sodium phenylbutyrate) for treatment of various other inborn errors of metabolism, including Maple Syrup Urine Disease (MSUD); ACER-801 (osanetant) for treatment of induced Vasomotor Symptoms (iVMS) and Post-traumatic Stress Disorder (PTSD); EDSIVO™ (celiprolol) for treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, Zika, dengue, Ebola and COVID-19. For more information, visit www.acertx.com.

 

Acer Contacts

Corporate contact:

Jim DeNike

Acer Therapeutics Inc.

jdenike@acertx.com

+1-844-902-6100

 

Investor contact:

Nick Colangelo

Gilmartin Group

nick@gilmartinIR.com

+1-332-895-3226

 

# # #

 

 GRAPHIC 3 gyu5p51fhuah000001.jpg GRAPHIC begin 644 gyu5p51fhuah000001.jpg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end EX-101.SCH 4 acer-20221229.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 acer-20221229_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, Address Line Three Entity Address Address Line3 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 6 acer-20221229_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Dec. 29, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Entity Central Index Key 0001069308
Document Period End Date Dec. 29, 2022
Entity Registrant Name ACER THERAPEUTICS INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-33004
Entity Tax Identification Number 32-0426967
Entity Address, Address Line One One Gateway Center
Entity Address, Address Line Two Suite 356
Entity Address, Address Line Three 300 Washington Street
Entity Address, City or Town Newton
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02458
City Area Code 844
Local Phone Number 902-6100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol ACER
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 acer-8k_20221229_htm.xml IDEA: XBRL DOCUMENT 0001069308 2022-12-29 2022-12-29 false 0001069308 8-K 2022-12-29 ACER THERAPEUTICS INC. DE 001-33004 32-0426967 One Gateway Center Suite 356 300 Washington Street Newton MA 02458 844 902-6100 false false false false Common Stock, $0.0001 par value per share ACER NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports acer-8k_20221229.htm acer-20221229.xsd acer-20221229_lab.xml acer-20221229_pre.xml acer-ex991_22.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "acer-8k_20221229.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "acer-8k_20221229.htm" ] }, "labelLink": { "local": [ "acer-20221229_lab.xml" ] }, "presentationLink": { "local": [ "acer-20221229_pre.xml" ] }, "schema": { "local": [ "acer-20221229.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "acer", "nsuri": "http://www.acertx.com/20221229", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "acer-8k_20221229.htm", "contextRef": "C_0001069308_20221229_20221229", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "acer-8k_20221229.htm", "contextRef": "C_0001069308_20221229_20221229", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address Address Line3", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.acertx.com/20221229/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001564590-22-039861-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-039861-xbrl.zip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end